FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order

View source ↗

Summary

FDA announces accelerated actions to improve access to treatments for serious mental illness following an Executive Order.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Serious Mental Illness

Snippet

On April 18, President Trump issued an Executive Order directing the U.S. Department of Health and Human Services (HHS) to accelerate access to treatments for patients with serious mental illness, including devastating, complex, and treatment-resistant conditions.